Pure Global

Online, Gut-directed Hypnotherapy for Patients With Irritable Bowel Syndrome (IBS) - Trial NCT06297785

Access comprehensive clinical trial information for NCT06297785 through Pure Global AI's free database. This phase not specified trial is sponsored by Sahlgrenska University Hospital, Sweden and is currently Recruiting. The study focuses on IBS - Irritable Bowel Syndrome. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06297785
Recruiting
behavioral
Trial Details
ClinicalTrials.gov • NCT06297785
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Online, Gut-directed Hypnotherapy for Patients With Irritable Bowel Syndrome (IBS)

Study Focus

Gut-directed hypnotherapy

Interventional

behavioral

Sponsor & Location

Sahlgrenska University Hospital, Sweden

Gothenburg,Gothenburg, Sweden

Timeline & Enrollment

N/A

Oct 17, 2022

Apr 01, 2027

50 participants

Primary Outcome

Change in gastrointestinal symptom severity measured by the IBS Severity Scoring System questionnaire (IBS-SSS)

Summary

Adult IBS patients with symptoms refractory to standard medical treatment will receive online
 nurse-administered, gut-directed hypnotherapy in groups. The primary outcome measure was
 change in gastro-intestinal symptom severity.

ICD-10 Classifications

Irritable bowel syndrome with predominant constipation [IBS-C]
Irritable bowel syndrome
Irritable bowel syndrome with predominant diarrhoea [IBS-D]
Irritable bowel syndrome with mixed bowel habits [IBS-M]
Other and unspecified irritable bowel syndrome

Data Source

ClinicalTrials.gov

NCT06297785

Non-Device Trial